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ABSTRACT 
Diabetes is now becoming a major public health problem globally. It is increasingly associated with renal diseases, particularly 
chronic kidney disease worldwide. A simple, accurate, reproducible and non-invasive method of evaluation is necessary for early 
morphological assessment for timely intervention, diagnosis, treatment, and evaluation of renal diseases in diabetes mellitus. In 
this cross-sectional comparative study, among one hundred and four adult diabetic cases and fifty-three healthy controls, the 
ultrasonographic renal dimensions were determined and compared in both cases and controls. Correlations were sought between 
the renal dimensions and the clinical, anthropometric, and metabolic characteristics of the study population. The dimensions of 
the kidneys in diabetic cases versus controls were; lengths (9.94± 0.76cm vs 9.27 ± 0.90 and 10.28 ± 0.87cm vs 9.41± 
1.02cm(p=<0.001), cortical thickness (1.77± 0.28cm vs 1.26± 0.49cm, p<0.001 and 1.89± 0.52cm vs 1.37± 0.78cm, p<0.001 and 
volumes (121.9± 39.50cm3 vs 107.8± 29.82cm, p=0.026 and 136.3± 45.09cm3 vs 118.8± 33.79cm3, (p=0.015) were significantly 
higher in Diabetes mellitus cases on the right and left respectively. The waist circumference, fasting blood sugar, postprandial 
blood sugar, cholesterol, and urinary albumin, all had correlations with the mean kidney length. Taking together, the 
ultrasonographic renal lengths, cortical thickness, and volumes are increased in diabetic disease without renal function 
compromise compared to age-, gender- and body mass index-matched non-diabetic controls. The clinical, anthropometric, and 
metabolic parameters of the diabetes cases also showed significant correlations with mean kidney length. 
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INTRODUCTION 
Diabetes mellitus (DM), a metabolic disorder of multiple 
aetiologies characterized by hyperglycaemia from defects in 
insulin secretion, insulin action or both (WHO 1999; Pradeep 
2010), has become a major public health concern globally 
(WHO 2015; Blas & Karup 2010; Chen et al, 2011), with 
serious socioeconomic burden from its management (Ala et al. 
2013; Bommer et al, 2017). DM is one of the most complex 
chronic systemic diseases with long-term damage, dysfunction 
and failure of various body organs with about 1.5-2.2 million 
yearly deaths, mostly before the age of 70 years (WHO, 
2016a).  
 In the developing countries, rapid urbanization, dietary 
changes, and increasing sedentary lifestyles are responsible for 
increased morbidity and mortality from DM (Frank, 2011), 
which in turn places huge financial stress on the already 
overloaded healthcare systems in Africa (Mbanya,2007). 
According to the diabetes country profiles, the prevalence of 
Diabetes in Nigeria is 4.3% (WHO, 2016), but varies from 0-
2% in rural areas to about 5-11% in urban areas of Nigeria 
(Fasanmade and Dagogo-Jack, 2015).  
 Type 2 diabetes, which accounts for over 90% of Diabetes, 
have been reported to be more susceptible to different forms 
of both short- and long-term macrovascular, microvascular 
diseases and cancers (Larsson and Wolk 2011; Vigersky et al, 
2011; Yanling Wu et al. 2014). Over the years, Diabetes and 
hypertension were both major risk factors for kidney disease 
(Jha et al, 2013). However, between 1990 and 2013 there was 
a decrease in the age-standardized rates for chronic kidney 
disease (CKD) due to hypertension by 22.4%, while the rates 
for CKD due to diabetes mellitus increased by 10.6% globally 
(Global Burden of Disease Study, 2015) which may be as a 
result of the continued increase in cases of Diabetes over the 
years. The effect of Diabetes on the kidneys is so serious that 
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about a third to half of the individuals with Diabetes develop 
kidney disease (Bakris 2011; Harjutsalo et al, 2014). 
 The prevalence of kidney diseases is on the increase in 
Sub-Sahara Africa this is projected to reach 34.3 million DM 
cases by the year 2040 from 14.2 million in 2015. Out of this 
number, Nigeria is said to account for 20% of all diabetes cases 
in the region (International Diabetes Federation, 2014). In 
addition to this high number of people with Diabetes in Nigeria 
is the problem of a high proportion of individuals with late 
diagnosis and those who remain undiagnosed or untreated (70-
80%) (International Diabetes Federation, 2014; Oguejiofor et 
al., 2014; Fasanmade and Dagogo-Jack, 2015) as well as the 
increased cost of managing diabetic patients with renal 
impairment (WHO, 2016b).  
 Although laboratory parameters such as albumin excretion 
rate (AER) and the estimated Glomerular Filtration Rate (e-
GFR) are employed in screening of chronic kidney disease in 
patients with Diabetes [Kramer and Molitch, 2005). Several 
researchers have reported that changes in the size and shape of 
the kidneys from diabetic kidney damage occur earlier than the 
AER and eGFR changes (Soheilipour et al, 2016; Premaratne 
et al. 2005; Fioretto et al, 2008). Also, the fact that kidney 
assessment in routine clinical practice may either involve 
invasive renal biopsies or expensive GFR determinations 
(Ibrahim et al. 2005; Chudleigh et al., 2007) has necessitated 
the use of a simple but cost-effective method, for early 
detection of morphological renal changes in diabetic patients 
in order to initiate timely intervention. An example is the 
estimation of kidney dimension, which is an important 
criterion in the diagnosis, treatment, and evaluation of renal 
disease (Muthusami et al., 2014). Although ultrasonography, 
computed tomography (CT) scan, magnetic resonance 
imaging (MRI) are the methods of choice in urological as well 
as nephrological practices currently (Moorthy and Venogopal, 
2011), renal ultrasonography has emerged as a simple, 
affordable, reliable, ionizing radiation-free and non-invasive 
imaging technique compared to CT and MRI for routine 
clinical practice. This is because CT involves the use of 
ionizing radiation and contrast media for measurement of renal 
dimensions and MRI is very expensive and not readily 
available. Thus, this study aimed to evaluate renal dimensions 
in type two diabetes without CKD using ultrasonography and 
to seek correlations, if any, between the renal dimensions and 
selected Diabetes mellitus clinico-laboratory risk factors. 
 
MATERIALS AND METHODS 
 
Study design and setting: This was a cross-sectional 
comparative study design. Cases were recruited from the 
Endocrinology clinic of the University College Hospital 
(UCH), Ibadan, Nigeria, while controls were selected among 
non-diabetic, normotensive patients from the General 
outpatient’s department of UCH and healthy volunteers, 
between July 2016 and April 2017. The UCH is a foremost 
tertiary referral hospital located in Ibadan, South-West of 
Nigeria.  
 
Study population and sampling: Cases were adults aged 18 
years and above who presented with symptoms and signs of 
Diabetes (polyuria, polydipsia, weight loss) that met blood 
sugar level criteria for Diabetes (random plasma glucose 
concentration > 200mg/dl (11mmmol/l); fasting (>8hours) 
plasma glucose>126mg/dl(7mmol.l) and 2-hour postprandial 
glucose >200mg/dl during oral glucose tolerance 
test(American Diabetes Association, 2013). While healthy 
normotensive, non-diabetic adults, without renal or vascular 
diseases of similar age and socioeconomic status who had no 
symptoms and had normal range blood glucose levels were the 
control group. The controls were recruited from the GOPD 
University College Hospital and healthy volunteers. 
 
Data collection and laboratory procedures: A pre-tested 
structured data form was administered to the participants at the 
time of recruitment. The socio-demographic data, weight in 
kilograms (kg), and height in metres (m) obtained using a 
stadiometer were recorded, and the BMI calculated as BMI= 
weight (kg)/height2 (m2) calculated. The participants’ blood 
pressure measurement was done with an appropriate size cuff 
Mercury sphygmomanometer and recorded in mmHg. 
Information about the duration of type 2 diabetes mellitus was 
taken from the patients’ clinical records. The relevant biodata 
and profiles above were documented in the datasheet.  
 Laboratory investigations carried out after an overnight 
fast for at least 8 hours and venous blood obtained for blood 
sugar (FBS) measurement on the morning of the renal 
dimension evaluation. Controls were screened for diabetes 
mellitus using the glucometer. Recent glycosylated 
haemoglobin and electrolyte and urea, as well as urinary 
albumin, were documented from the patients’ case file. Blood 
samples were also obtained for serum lipids among the control 
and subjects. eGFR was calculated for each patient (KDOQI 
clinical practice guidelines, 2007).  
 
Ultrasonographic procedures: All subjects had both kidneys 
scanned using a General Electric Logic P5 ultrasound scanner 
with a 2–5 MHz curved array transabdominal transducer. All 
participants were scanned in the supine and decubitus 
positions with the liver and spleen used as acoustic windows 
for the kidneys on the right and left, respectively. Each kidney 
was scanned in the longitudinal and transverse planes and the 
renal dimensions, length, width, anteroposterior diameter, and 
cortical thickness measured in centimeters. All patients were 
scanned by a certified radiologist while blinded to the 
laboratory test results.         
 The acquired measurements were recorded in a data form. 
Variables, data handling, and analysis on the kidney length, 
width, anteroposterior size, and cortical thickness were done 
using SPSS 23.0 statistical software (SPSS Inc. IL., USA). 
Kidney volume was estimated using the ellipsoid formula 
(Bauker et al, 1999). 
 
Ethical considerations: Participation in the study was 
completely voluntary and based on written informed consent. 
Participants were made to understand that they were free to 
withdraw their consent at any time and that they will continue 
to receive a standard level of care, even in such a situation. 
The privacy of participants was maintained by using serial 
numbers on the case record forms. The study protocol was 
approved by the University of Ibadan/University College 
Hospital Ethical Review Committee with approval number 
UI/EC/15/0271. 
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RESULTS 
 
One hundred and fifty-seven participants were recruited for 
this study, and about 66.2% (104) had Diabetes, while 33.8% 
(53) were normal. The mean age of the participants in the DM 
group was 59.9 ± 10.13 years with an age range of 34-84years, 
while the mean age for controls was 58.9 ± 9.5 years with a 
range of 38-80 years. Diabetes was highest among the age 
group 60 to 69 years (40.4%) followed by age group 50 to 59 
years (27.9%). About 38% (20/53) of the controls were males 
while among the people with Diabetes 31% (32/104) were 
males. (Table 1). 
 
Table 1:  
Sex and Gender Distribution Of The Study Population  
Variables Control  






   Male 











   Below 40 years 
   40 - 49 years 
   50 - 59 years 
   60 - 69 years 


















 There were significant differences between the waist 
circumference in the diabetic group (Mean = 92.73 ± 
11.73cm) and the control group (Mean= 80.36 ± 8.20 cm) p 
<0.001. Similar significant differences were noted between 
the systolic and diastolic blood pressure p <0.001 respectively 
between participants with diabetes (Mean SBP = 127.9 ± 
19.17 mmHg, Mean DBP= 77.46 ± 12.47 mmHg) and controls 
(Mean SBP = 109.0 ± 8.11 mmHg, Mean DBP = 71.92 ± 5.39 
mmHg). The mean arterial blood pressure was significantly 
different in diabetics (Mean = 94.22 ± 13.54) than in controls 
(Mean = 84.30 ± 5.21) p <0.001. Also, the FBS showed 
statistically significantly differences in the diabetic group 
(Mean = 123.1 ± 25.06 mg/dl) compared to the control group 
(Mean = 80.85 ± 15.26 mg/dl) p <0.001. Likewise, diabetic 
participants had higher HbA1c (Mean = 5.74 ± 0.84) than in 
the control group (Mean = 4.99 ± 0.36) p <0.001. Similarly, 
there was significant difference in serum creatinine between 
participants with diabetes (Mean = 1.3 ± 0.64mg/dl) and 
controls (Mean = 0.56 ± 0.26mg/dl) p <0.001. Furthermore, 
there was also statistically significant difference in the eGFR 
between diabetics (Mean = 70.59 ± 39.13mL/min/1.73 m2) 
and controls (Mean = 130.57 ± 39.22 mL/min/1.73 m2) p 
<0.001, as shown in Table 2. 
 
Renal ultrasonographic measurement: The renal 
measurements showed significant differences among 
participants with diabetes’ right and left kidney LS (Mean 
right kidney LS = 9.94 ± 0.76cm, Mean left kidney LS = 10.28 
± 0.87cm) and the control group (Mean right kidney LS = 9.27 
± 0.90cm, Mean left kidney LS = 9.41 ± 1.02cm) p<0.001.
 
Table 2:  
Age, Clinical Factors And Biochemical Parameter Comparison Among The Control And Diabetic Group  
Variables Control group Diabetic group  
Mean SD Mean SD p-value 
Age (years) 58.89 9.53 59.85 10.13 0.777 
Waist circumference (cm) 80.36 8.20 92.73 11.73 <0.001 
Systolic blood pressure (mmHg) 109.0 8.11 127.9 19.17 <0.001 
Diastolic blood pressure (mmHg) 71.92 5.39 77.46 12.47 <0.001 
FBS (mg/dl) 80.85 15.26 123.1 25.06 <0.001 
HbA1c (mg/dl) 4.99 0.36 5.74 0.84 <0.001 
Serum creatinine (mg/dl) 0.56 0.26 1.31 0.64 <0.001 
BMI (kg/m2) 25.22 3.97 25.00 4.01 0.743 
Mean arterial blood pressure (mmHg) 84.30 5.21 94.22 13.54 <0.001 
eGFR (ML/min/1.73m2) 130.6 39.22 70.59 39.13 <0.001 
FBS = Fasting blood sugar; HbA1c = Glycosylated haemoglobin; BMI = Body mass index; eGFR = estimated Glomerular filtration rate. 
 
Table 3:  
Renal Kidney Dimensions Among the Control And Diabetic Group  
Variables CONTROLS DM PATIENTS  
Mean SD Mean SD p-value 
Right kidney LS (cm) 9.27 0.90 9.94 0.76 <0.001 
Left kidney LS (cm) 9.41 1.02 10.28 0.87 <0.001 
Right kidney AP (cm) 4.10 0.52 4.35 0.71 0.012 
Left kidney AP (cm) 4.46 0.56 4.65 0.78 0.107 
Right kidney cortical thickness (cm) 1.26 0.49 1.77 0.28 <0.001 
Left kidney cortical thickness (cm) 1.37 0.78 1.90 0.52 <0.001 
Right kidney volume (cm3) 107.8 29.82 121.9 39.50 0.026 
Left kidney volume(cm3) 118.8 33.79 136.3 45.09 0.015 
Right kidney TS (cm) 5.60 0.93 5.55 0.81 0.726 
Left kidney TS (cm) 5.58 0.72 5.59 0.99 0.987 
LS = longitudinal length; AP =Antero-posterior; TS = transverse; SD = Standard deviation. 
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Table 4:  
Correlation Between Kidney Dimensions, Age, Clinical, and Laboratory Parameters among the Diabetic Cases 








 r p-value r p-value r p-value r p-value 
Age (years) 0.042 0.672 -0.099 0.333 -0.059 0.550 0.185 0.062 
Waist circumference (cm) 0.227 0.020 0.144 0.157 0.119 0.230 0.180 0.069 
Duration of DM 0.150 0.180 0.089 0.430 0.152 0.174 0.233 0.039 
SBP (mmHg) -0.183 0.063 0.046 0.104 0.167 0.090 -0.219 0.026 
DBP (mmHg) -0.211 0.031 -0.015 0.880 0.203 0.039 -0.189 0.056 
FBS (mg/dl) -0.236 0.016 -0.110 0.282 -0.077 0.434 -0.019 0.845 
PPBS (mg/dl) -0.293 0.003 -0.130 0.205 0.032 0.751 -0.172 0.084 
Cholesterol (mg/dl) -0.100 0.310 -0.055 0.593 -0.023 0.818 -0.079 0.430 
HbA1c (mg/dl) 0.066 0.508 0.008 0.935 -0.054 0.585 0.319 0.001 
Creatinine (mg/dl) 0.015 0.879 0.035 0.735 0.097 0.329 -0.064 0.522 
UA (mg/dl) -0.259 0.009 -0.067 0.522 0.100 0.321 -0.019 0.850 
BMI (Kg/m2) 0.033 0.742 -0.037 0.718 -0.011 0.915 0.047 0.636 
MAP  -0.213 0.030 0.021 0.838 0.204 0.038 -0.221 0.025 
eGFR (ml/min/1.73m2) 0.081 0.419 0.092 0.370 -0.60 0.550 0.005 0.963 
SBP=Systolic blood pressure; DBP=Diastolic blood pressure, HbA1c=glycosylated haemoglobin; UA=urinary albumin; MAP=Mean 
arterial pressure; eGFR=estimated glomerular filtration rate and r = Pearson’s correlation coefficient. 
 
The right kidney AP among diabetics (mean = 4.35 ± 0.71cm) 
had significant difference with the AP of the control group 
(mean = 4.10 ± 0.52cm). p= 0.02. There was also a statistically 
significant difference in the right kidney cortical thickness 
between participants with diabetes (mean = 1.77 ± 0.28 cm) 
and the controls (mean = 1.26 ± 0.49 cm) p<0.001. Likewise, 
participants with diabetes had significant thicker left kidney 
cortex (mean = 1.89 ± 0.52 cm) than the controls (mean = 1.37 
± 0.78 cm) p<0.001. Similarly, the right and the left kidney 
volumes were significantly different in the diabetic cases 
(mean right kidney= 121.90 ± 39.50cm3; left kidney 136.31 ± 
45.09cm3), compared to the controls (mean = 107.81 ± 
29.82cm3; left kidney=118.82 ± 33.79cm3) with a p value of 
0.026 and 0.015 on the right and left respectively. (Table 3). 
Comparing the renal dimensions in both sexes, only the right 
kidney AP showed significant difference between males (4.42 
± 0.73cm) and females (4.19 ± 0.62cm), p = 0.037. Other 
kidney measurements showed no significant differences, 
p>0.05. The male and female kidney dimensions are; right 
kidney LS= 9.72±0.85 cm and 9.71±0.88cm (p=0.977); left 
kidney LS = 10.07±0.98cm and 9.94cm±1.02cm (p=0.446); 
right cortical thickness =1.65±0.43cm and 1.57±0.44cm 
(p=0.298); left kidney cortical thickness =1.73±0.48cm and 
1.72±0.75cm (p=0.927); Right kidney 
volume=123.2±42.77cm3 and 114±33.34cm3(p=0.185); left 
kidney volume =131.9±37.94cm3 and 129.3 ±44.10cm3 
(p=0.733). 
 
Correlation of clinical and laboratory factors and renal 
dimensions: Table 4 showed that among patients with 
diabetes, waist circumference had a statistically significant 
correlation with the mean kidney length (r = 0.227, p=0.020). 
Likewise, the diastolic blood pressure had a statistically 
significant correlation with the mean kidney length (r = -
0.211, p=0.031). MAP had statistically significant correlations 
with kidney length (r = -0.213, p=0.030). Among the 
laboratory parameters, the FBS had a significant correlation 
with mean kidney length (r = -0.236, p=0.016). Similar 
correlations were seen between the PPBS and mean kidney 
length (r = -0.293, p=0.003); as well as between the urinary 
albumin and the mean kidney length (r = -0.259, p=0.009). 
The cholesterol level, however, had no significant correlation 
with the kidney length (r = -0.100, p=0.310). 
 Furthermore, the kidney AP showed significant 
correlation with diastolic blood pressure (r = 0.203, p=0.039) 
and MAP (r = 0.204, p=0.038) respectively while the kidney 
cortical thickness had statistically significant correlation with 
duration of diabetes (r = 0.233, p=0.039), systolic blood 
pressure (r = -0.219, p=0.026), HbA1c (r = 0.319, p=0.001) 




This hospital-based comparative study among type 2 diabetes 
patients with age, sex, and BMI-matched controls provides 
information about the association between certain 
physiological and biochemical variables, renal dimension, and 
Diabetes. Findings from this study showed an expected 
increase in the number of diabetic patients with increasing age 
and a peak in the age group 60 to 69 years. Fiagbe et al. (2017) 
reported a similar trend in their study among 210 participants 
(70 cases and 140 controls), in which about 61.4% of diabetic 
patients are 60 years and above.  
This current study also showed the importance of certain 
physiological and biochemical factors as possible risk factors 
for Diabetes. Waist circumference, systolic blood pressure 
diastolic blood pressure, FBS (mg/dl), HbA1c (mg/dl), serum 
creatinine, and mean arterial blood pressure were significantly 
higher in patients with Diabetes than in the control group. At 
the same time, eGFR was significantly lower among patients 
with Diabetes compared to the control group. This is 
congruent with previous studies (González-Villalpando et al, 
2014; Mitta et al, 2010; Madhusudan and Sadhvimani, 2017).  
Adebamowo et al. (2016) in their study on the impact of Type 
2 diabetes on impaired kidney function in sub-Saharan African 
populations reported a higher level in serum creatinine among 
participants with type 2 diabetes (88.4 ± 44.2 μmol/l) 
compared to participants without type 2 diabetes (79.6 ± 17.7 
Ultrasonographic renal dimensions among Nigerian Diabetics 
 Afr. J. Biomed. Res. Vol. 23, (SE) July 2020  Assenyi & Adekanmi 89 
μmol/l). Also, when eGFR was compared between the two 
groups in this study, it reported a lower mean eGFR for those 
with type 2 diabetes with a p-value <0.001. Likewise, similar 
to our findings, Hameed et al. (2017) reported that fasting 
blood glucose, systolic pressure, diastolic pressure, and 
HbA1c were significantly higher among diabetic patients 
compared to the control groups (p<0.001). Expectedly, the 
values of most of the physiological and biochemical variables 
in the diabetic group that showed a significant difference 
between diabetic patients and the control group in our current 
study were within a normal range since most of the diabetic 
patients were already under treatment. However, serum 
creatinine in the diabetic group was higher than the normal 
range (<1.20mg/dl). This may be an indicator of early-stage 
kidney diseases in diabetic patients.   However, the mean 
eGFR of 70.59ml/min/1.73m2 among the diabetes cases 
showed that the majority of these cases were not in the 
nephropathy range, usually describe as <60ml/min/1.73m2 
(Kramer and Molitch, 2005).  
 Renal dimensions except for left kidney AP and both 
kidney TS also showed a significant difference between the 
control group and diabetic patients in this present study. 
Patients with Diabetes had statistically significant higher renal 
length, cortical thickness, and renal volume compared to the 
control group, in keeping with renomegaly in the diabetic 
group. This result is similar to findings by previous studies 
that diabetes mellitus does not lead to a reduction in kidney 
sizes in its initial phase (Paivansalo et al, 1998; John et al, 
2018; Mancini et al, 2013). Further analysis of the mean renal 
dimensions in our study showed that only the renal length was 
independently associated with Diabetes (AOR 16.69; 95% CI 
= 1.03, 132.3; p =0.047) which indicates that renal length may 
be an important determinant for Diabetes in our study 
population. Kidney damage is common among diabetic 
patients (Afkarian et al, 2016) and screening of Chronic 
Kidney Disease (CKD) in patients with Diabetes is based on 
the Albumin excretion rate (AER, threshold: 30 mg/24hours) 
and the estimated Glomerular Filtration Rate threshold of 60 
mL/min/1.73 m2 (Kramer and Molitch, 2005). However, 
several studies have reported a significant correlation between 
renal dimension and several indicators of kidney function, 
thereby regarding renal dimensions as important parameters in 
making an ultrasonographic diagnosis/ prognosis (El-Reshaid 
et al, 2014; Kariyanna et al, 2010; Korkmaz et al, 2018).  
 The left kidney dimensions were higher than that of the 
right kidney, in agreement with the findings of Saeed et al. 
(2012), and adduced to the fact that the smaller volume of the 
spleen on the left compared to the liver and the shorter and 
straighter left renal artery course causing increased blood flow 
results in larger growth of the left kidneys in the study 
population. 
 Also, findings from this study showed that renal length 
had correlations with more predictors of kidney function in a 
diabetic patient than other renal dimensions. This agrees with 
previous studies that renal length may be an important 
indicator of the prognosis and diagnosis of renal dysfunction 
(Sanusi et al, 2009). Other studies in diabetes have shown that 
the renal cortical thickness has a significant correlation with 
the glomerular filtration rate (Yamashita et al, 2015), and that, 
the HbA1c shows long term assessment of glycaemic control 
(WHO, 2011; Modi, 2016). The correlation between cortical 
thickness, duration of Diabetes, and HbA1c, in this study, 
suggest that renal cortical thickness maybe an indicator of 
Diabetes chronicity and long-term compliance with diabetic 
control. Although in this current study, there was no 
significant correlation between renal dimensions and eGFR 
(Rigalleau et al. 2010). However, renal dimension had a 
significant correlation with fasting glucose, MAP and urinary 
albumin which is associated with eGFR/or kidney function 
(Wang et al, 2017; Sirivole and Eturi, 2017) which indicates 
that renal dimension may also provide information regarding 
disease progression or stability (Ali Omer et al, 2014; Zira, 
2017).  
 In conclusion, the ultrasonographic renal lengths, cortical 
thickness, and volumes are increased in diabetic disease 
without renal function compromise compared to age-, gender- 
and body mass index-matched non-diabetic controls. The 
clinical, anthropometric, and metabolic parameters of the 
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